β-Lactamase inhibitory activities and synergistic effects of 5,6-cis-carbapenem antibiotics

14Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Twelve 5,6-cis-carbapenem antibiotics were examined for their β-lactamase inhibitory activities, their types of inhibitions, and their synergistic activities with otherβ-lactam antibiotics. All the carbapenems inhibited eight types of β-lactamases including cephalosporinases which were insensitive to clavulanic acid and sulbactam. The sulfonyloxy ethyl carbapenems were the most active inhibitors; they inhibited allβ-lactamases in a progressive fashion, whereas some of the hydroxyl compounds exerted non-progressive inhibition against severalβ-lact-amases such as those of Escherichia coli TN713 and Proteus vulgaris GN4413. Several carbapenems were inactivated by the β-lactamases of Citrobacter freundii GN1706, P. vulgaris GN4413, E. coli TN713, and Klebsiella pneumoniae TNI 698. Most of the carbapenems potentiated the antibacterial activities of ampicillin and cefotiam against β-lactamase-producing bacteria. © 1982, JAPAN ANTIBIOTICS RESEARCH ASSOCIATION. All rights reserved.

Cite

CITATION STYLE

APA

Okonogi, K., Harada, S., Shinagawa, S., Imada, A., & Kuno, M. (1982). β-Lactamase inhibitory activities and synergistic effects of 5,6-cis-carbapenem antibiotics. The Journal of Antibiotics, 35(8), 963–971. https://doi.org/10.7164/antibiotics.35.963

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free